LifeVantage Corporation LFVN

SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026. The webcast of the presentation will begin at approximately 1:30 p.m. Eastern Time

Moby summary of LifeVantage Corporation's Q4 2026 earnings call

New CEO outlines turnaround plan as subscription base remains resilient despite macroeconomic headwinds

SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026. Fourth Quarter Fiscal 2026 Summary*: Revenue was $42.4 million, a decrease of 23.1% from the prior year period;Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;

SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026. About LifeVantage Corporation LifeVantage Cor

SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that

SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s new President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan (the “New Employee Plan”) as an inducement material to Mr. Moorehead’s employment in accordance with Nasdaq Listing Rule 5635(c)(4). The awards were granted on Augus

SALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced Terrence Moorehead has officially joined the Company as President and Chief Executive Officer and as a member of the Board of Directors. Moorehead’s appointment was previously announced on April 16, 2026. Moorehead brings over 25 years of g

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

LifeVantage Corporation (NASDAQ:LFVN) is included among the 12 Best Micro-Cap Dividend Stocks to Buy Now. On May 7, Lake Street downgraded LifeVantage Corporation (NASDAQ:LFVN) to Hold from Buy and set a $5 price target after the company reported weaker-than-expected Q3 results. The analyst said management kept its prior FY26 guidance framework in place but now expects […]

Moby summary of LifeVantage Corporation's Q3 2026 earnings call

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: Revenue was $43.7 million, a decrease of 25.2% from the prior year period;Revenue in the Americas decreased 28.9%, and revenue in Asia/Pacific & Europe decreased 7.7%;Net